Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple Negative Breast Cancer Markers in Liquid Biopsies Using Artificial Intelligence (TRICIA Study)

NCT04874064 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.

NCT NCT04874064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04874064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple Negative Breast Cancer Markers in Liquid Biopsies Using Artificial Intelligence (TRICIA Study)
Lead sponsor
Jewish General Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 5, 2019
Completion date
December 31, 2027
Enrollment
130 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer